Spinal muscular atrophies

This article is about a category of rare disorders. For the most common form, see Spinal muscular atrophy.

Spinal muscular atrophies
Location of neurons affected in spinal muscular atrophies
Classification and external resources
Specialty	neurology
ICD-10	G12
MeSH	D009134

Spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of rare debilitating disorders characterised by the degeneration of lower motor neurons (neuronal cells situated in the anterior horn of spinal cord) and subsequent atrophy (wasting) of various muscle groups in the body.^[1] While some SMAs lead to early infant death, other types permit normal adult life with only mild weakness.

Classification

Based on the type of muscles affected, spinal muscular atrophies can be divided into:

Proximal spinal muscular atrophies, i.e., conditions that affect primarily proximal muscles;
Distal spinal muscular atrophies (which significantly overlap with distal hereditary motor neuropathies) where they affect primarily distal muscles.

When taking into account prevalence, spinal muscular atrophies are traditionally divided into:

Autosomal recessive proximal spinal muscular atrophy, responsible for 90-95% of cases and usually called simply spinal muscular atrophy (SMA) – a disorder associated with a genetic mutation on the SMN1 gene on chromosome 5q (locus 5q13), affecting people of any age but in its most severe form being the most common genetic cause of infant death;
Localised spinal muscular atrophies – much more rare conditions, in some instances described in but a few patients in the world, which are associated with mutations of genes other than SMN1 and for this reason sometimes termed simply non-5q spinal muscular atrophies.

A more detailed classification is based on the gene associated with the condition (where identified) and is presented in table below.

Group	Name Alternate names	OMIM	Gene	Locus	Mode of inheritance	Characteristics
SMA	Spinal muscular atrophy (SMA) Autosomal recessive proximal spinal muscular atrophy Werdnig–Hoffmann disease / Kugelberg–Welander disease	253300 253550 253400 271150	SMN1	5q13.2	Autosomal recessive	Affects primarily proximal muscles in people of all ages, progressive, relatively common
XLSMA	X-linked spinal muscular atrophy type 1 (SMAX1) Spinal and bulbar muscular atrophy (SBMA) Kennedy's disease (KD)	313200	NR3C4	Xq12	X-linked recessive	Affects primarily bulbar muscles as well as sensory nerves mainly in adult men, progressive
	X-linked spinal muscular atrophy type 2 (SMAX2) Arthrogryposis multiplex congenita – X-linked type 1 (AMCX1)	301830	UBA1	Xp11.23	X-linked recessive	Characterised by bone fractures, affects mainly distal muscles in newborn boys, usually fatal in infancy
	X-linked spinal muscular atrophy type 3 (SMAX3) Distal spinal muscular atrophy – X-linked (DSMAX)	300489	ATP7A	Xq21.1	X-linked recessive	Affects distal muscles of all extremities mainly in boys, slowly progressive
DSMA	Distal spinal muscular atrophy type 1 (DSMA1) Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Distal hereditary motor neuropathy type 6 (HMN6)	604320	IGHMBP2	11q13.3	Autosomal recessive	Affects mainly infant boys, similar to SMA type 1 but with diaphragmatic paralysis
	Distal spinal muscular atrophy type 2 (DSMA2) Distal hereditary motor neuropathy – Jerash type (HMN-J)	605726	SIGMAR1	19p13.3	Autosomal recessive	Slowly progressive
	Distal spinal muscular atrophy type 3 (DSMA3) Distal hereditary motor neuropathy types 3 & 4 (HMN3, HMN4)	607088	?	11q13.3	Autosomal recessive	Slowly progressive
	Distal spinal muscular atrophy type 4 (DSMA4)	611067	PLEKHG5	1p36.31	Autosomal recessive	Slowly progressive, described only in one family
	Distal spinal muscular atrophy type 5 (DSMA5)	614881	DNAJB2	2q35	Autosomal recessive	Young adult onset, slowly progressive
	Distal spinal muscular atrophy type VA (DSMAVA) Distal hereditary motor neuropathy type 5A (HMN5A)	600794	GARS	7p14.3	Autosomal dominant	With upper limb predominance; allelic and overlapping with CMT2D, phenotype overlapping with Silver syndrome
	Distal spinal muscular atrophy type VB (DSMAVB) Distal hereditary motor neuropathy type 5B (HMN5B)	614751	REEP1	2p11	Autosomal dominant	With upper limb predominance; allelic and overlapping with HSP-31
	Distal spinal muscular atrophy with calf predominance Distal hereditary motor neuropathy type 2D (HMN2D)	615575	FBXO38	5q32	Autosomal dominant	Juvenile- or adult-onset, slowly progressive, affects both proximal and distal muscles, initially manifests with calf weakness which progresses to hands
	Distal spinal muscular atrophy with vocal cord paralysis Distal hereditary motor neuropathy type 7A (HMN7A) Harper–Young myopathy	158580	SLC5A7	2q12.3	Autosomal dominant	Adult-onset with vocal cord paralysis, very rare
ADSMA	Autosomal dominant distal spinal muscular atrophy Distal hereditary motor neuropathy type 2A (HMN2A)	158590	HSPB8	12q24.23	Autosomal dominant	Adult-onset. Allelic with Charcot–Marie–Tooth disease type 2L (CMT2L)
ADSMA	Autosomal dominant juvenile distal spinal muscular atrophy Distal hereditary motor neuropathy type 1 (HMN1)	182960	?	7q34–q36	Autosomal dominant	Juvenile-onset
	Congenital distal spinal muscular atrophy	600175	TRPV4	12q24.11	Autosomal dominant	Affects primarily distal muscles of lower limbs, non-progressive, rare, allelic with SPSMA and CMT2C
	Scapuloperoneal spinal muscular atrophy (SPSMA) Scapuloperoneal neurogenic amyotrophy	181405	TRPV4	12q24.11	Autosomal dominant or X-linked dominant	Affects muscles of lower limbs, non-progressive, rare, allelic with congenital distal spinal muscular atrophy and CMT2C
	Juvenile segmental spinal muscular atrophy (JSSMA)	183020	?	18q21.3	?	Juvenile-onset, progressive with stabilisation after 2–4 years, affects primarily hands, very rare
	Finkel-type proximal spinal muscular atrophy (SMA-FK)	182980	VAPB	20q13.32	Autosomal dominant	Late-onset, affects proximal muscles in adults
	Jokela-type spinal muscular atrophy (SMA-J)	615048	CHCHD10	22q11.2–q13.2	Autosomal dominant	Late-onset, slowly progressive, affects both proximal and distal muscles in adults
	Spinal muscular atrophy with lower extremity predominance 1 (SMALED1)	158600	DYNC1H1	14q32	Autosomal dominant	Affects proximal muscles in infants
	Spinal muscular atrophy with lower extremity predominance 2 (SMALED2)	615290	BICD2	9q22.31	Autosomal dominant	Congenital or early-onset, primarily affecting lower limbs, nonprogressive, very rare
	Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME)	159950	ASAH1	8p22	Autosomal recessive
	Spinal muscular atrophy with congenital bone fractures (SMA-CBF)	271225	?	?	Autosomal recessive (?)	Characterised by severe muscle wasting as in SMA type I accompanied by congenital bone fractures
PCH	Spinal muscular atrophy with pontocerebellar hypoplasia (SMA-PCH) Pontocerebellar hypoplasia type 1A (PCH1A)	607596	VRK1	14q32	Autosomal dominant	→ see Pontocerebellar hypoplasia
MMA	Juvenile asymmetric segmental spinal muscular atrophy (JASSMA) Monomelic amyotrophy; Hirayama disease; Sobue disease	602440	?	?	?	→ see Monomelic amyotrophy

In all forms of SMA (with an exception of X-linked spinal muscular atrophy type 1), only motor neurons, located at the anterior horn of spinal cord, are affected; sensory neurons, which are located at the posterior horn of spinal cord, are not affected. By contrast, hereditary disorders that cause both weakness due to motor denervation along with sensory impairment due to sensory denervation are known as hereditary motor and sensory neuropathies (HMSN).

Symptoms

In all spinal muscular atrophies, the primary feature is muscle weakness accompanied by atrophy of muscle. This is the result of denervation, or loss of the signal to contract that is transmitted by the motor neurons in the spinal cord. The signal is normally transmitted from the spinal cord to muscle via the motor neuron's axon, but in spinal muscular atrophies either the entire motor neuron or the motor neuron's axon loses the ability to transmit signals to muscles.

The symptoms are strongly related to the exact disease (see above) and, sometimes, to the age of onset. Certain conditions (e.g., spinal muscular atrophy or spinal and bulbar muscular atrophy) have a wide range, from infancy to adult, fatal to trivial, with different affected individuals manifesting every shade of impairment between these two extremes. Other muscular atrophies have a different and often very severe course. Some of them are extremely rare and described only in a handful of individuals. However, in all cases the majority of symptoms are a consequence of muscle weakness.

Diagnosis

While the presence of several symptoms may point towards a particular genetic disorder of the spinal muscular atrophy group, the actual disease can be established with full certainty only by genetic testing which detects the underlying genetic mutation.

Treatment

As with many genetic disorders, there is no known cure to any disorder of the spinal muscular atrophies group. The main objective is to improve quality of life which can be measured using specific questionnaires.^[2] Supportive therapies are widely employed for patients who often also require comprehensive medical care involving multiple disciplines, including pulmonology, neurology, orthopedic surgery, critical care, and clinical nutrition. Various forms of physiotherapy and occupational therapy are frequently able to slow down the pace of nerve degeneration and muscle wasting. Patients also benefit greatly from the use of assistive technology.

SMA Treatment Acceleration Act

Main article: SMA Treatment Acceleration Act

In 2007, an act of law called SMA Treatment Acceleration Act was introduced in the United States Congress in order to "authorize the Secretary of Health and Human Services to conduct activities to rapidly advance treatments for spinal muscular atrophy, neuromuscular disease, and other pediatric diseases, and for other purposes." As of 2012, it remains in a committee in the 111th Congress.

References

↑ "Spinal muscular atrophy". Genetics Home Reference. 2016-03-21. Retrieved 2016-03-26.
↑ Dany, Antoine; Barbe, Coralie; Rapin, Amandine; Réveillère, Christian; Hardouin, Jean-Benoit; Morrone, Isabella; Wolak-Thierry, Aurore; Dramé, Moustapha; Calmus, Arnaud; Sacconi, Sabrina; Bassez, Guillaume; Tiffreau, Vincent; Richard, Isabelle; Gallais, Benjamin; Prigent, Hélène; Taiar, Redha; Jolly, Damien; Novella, Jean-Luc; Boyer, François Constant (2015). "Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease". Quality of Life Research 24 (11): 2615–2623. doi:10.1007/s11136-015-1013-8. ISSN 0962-9343.

Brain	Encephalitis Viral encephalitis Herpesviral encephalitis Limbic encephalitis Encephalitis lethargica Cavernous sinus thrombosis Brain abscess Amoebic

Spinal cord	Myelitis: Poliomyelitis Demyelinating disease Transverse myelitis Tropical spastic paraparesis Epidural abscess

Both/either	Encephalomyelitis Acute disseminated Myalgic Meningoencephalitis

Brain/
encephalopathy

Degenerative

Extrapyramidal and movement disorders	Basal ganglia disease Parkinsonism PD Postencephalitic NMS PKAN Tauopathy PSP Striatonigral degeneration Hemiballismus HD OA Dyskinesia Dystonia Status dystonicus Spasmodic torticollis Meige's Blepharospasm Athetosis Chorea Choreoathetosis Myoclonus Myoclonic epilepsy Akathisia Tremor Essential tremor Intention tremor Restless legs Stiff person

Dementia	Tauopathy Alzheimer's Early-onset Primary progressive aphasia Frontotemporal dementia/Frontotemporal lobar degeneration Pick's Dementia with Lewy bodies Posterior cortical atrophy Vascular dementia

Mitochondrial disease	Leigh disease

Demyelinating

Episodic/
paroxysmal

Seizure/epilepsy	Focal Generalised Status epilepticus Myoclonic epilepsy

Headache	Migraine Familial hemiplegic Cluster Tension

Cerebrovascular	TIA Amaurosis fugax Transient global amnesia Acute aphasia Stroke MCA ACA PCA Foville's Millard–Gubler Lateral medullary Weber's Lacunar stroke

Sleep disorders	Insomnia Hypersomnia Sleep apnea Obstructive Ondine's curse Narcolepsy Cataplexy Kleine–Levin Circadian rhythm sleep disorder Advanced sleep phase disorder Delayed sleep phase disorder Non-24-hour sleep–wake disorder Jet lag

CSF

Other

Spinal cord/
myelopathy

Both/either

Degenerative

SA	Friedreich's ataxia Ataxia telangiectasia

MND	UMN only: Primary lateral sclerosis Pseudobulbar palsy Hereditary spastic paraplegia LMN only: Distal hereditary motor neuronopathies Spinal muscular atrophies SMA SMAX1 SMAX2 DSMA1 Congenital DSMA SMA-PCH SMA-LED SMA-PME Progressive muscular atrophy Progressive bulbar palsy Fazio–Londe Infantile progressive bulbar palsy both: Amyotrophic lateral sclerosis

Medicine

Specialties
and
subspecialties

Internal medicine

Allergy / Immunology Angiology Cardiology Endocrinology Gastroenterology Hepatology Geriatrics Hematology Hospital medicine Infectious disease Nephrology Oncology Pulmonology Rheumatology

Obstetrics and gynaecology

Gynaecology Gynecologic oncology Maternal–fetal medicine Obstetrics Reproductive endocrinology and infertility Urogynecology

Diagnostic

Radiology Interventional radiology Nuclear medicine Pathology Anatomical pathology Clinical pathology Clinical chemistry Clinical immunology Cytopathology Medical microbiology Transfusion medicine

Medical education